Nephrol Dial Transplant (2002) 17: 2244-2248
© 2002 European Renal Association-European Dialysis and Transplant Association
Technical Note
Glucose pump test: a new method for blood flow measurements
Nephrology Dialysis Unit, Sestri Levante Hospital, Aosta Hospital, Radiology Department Genoa University, Sestri Levante (Genoa), Italy
Abstract
Background. A good test for monitoring blood flow (Qa) must be accurate, rapid and economical in order to allow frequent easy measurements. The glucose pump test (GPT) is based on a constant glucose infusion as a dilutional indicator of Qa.
Methods. GPT protocol requires a constant glucose infusion, by a syringe pump, into the arterial needle and two blood withdrawals from the venous needle, one basal before the infusion (Ca1), the other (Ca2) 11 s after the start of the infusion. At the bedside we measure glucose on Ca1 and Ca2. Knowing the infused glucose concentration (Ci) and the pump infusion rate (Qi) we can easily calculate Qa=Qix(Ci–Ca2)/(Ca2–Ca1). We verified the accuracy of this new method by comparing it with the in vitro results from a circuit reproducing vascular access circulation, and in vivo comparing GPT-Qa with Doppler ultrasound in pre-dialysis to the Transonic HD01-Qa during dialysis in 23 chronic haemodialysis patients.
Results. GPT-Qa values were highly correlated with the in vitro Qa=1.01xGPT-Qa–16.6; r=0.94. There was agreement between the mean flow values of GPT and Doppler (927.5 and 927.1 ml/min, respectively; P=NS) while the mean value of HD01 was significantly lower (HD01-Qa=690 ml/min; P<0.001 vs GPT-Qa and Doppler-Qa). The regression analysis showed a good correlation between GPT and Transonic results (r=0.95; HD01-Qa=0.86xGPT-Qa–111.9), while there was a significant difference between the two measurements (mean 
235±117 ml/min; range from 15 to 451 ml/min). This difference could be caused by the large haemodynamic variations (different blood pressure, cardiac output, circulating effective volume, haematocrit) between pre-dialysis and intra-dialysis and in addition by the counter current flow during the reversal blood lines Transonic measurements.
Conclusions. GPT offers the advantage of a simple bedside procedure easily performed before dialysis: it does not interfere with the dialysis treatment and it is less intrusive for the patient as it does not involve reversal of the blood lines. The preliminary data indicate that our method could be a useful, simple and cheap test for monitoring access flow in every dialysis unit.
Keywords: constant infusion; glucose; vascular access
Notes
Correspondence and offprint requests to: Alberto Magnasco, Nephrology Dialysis Unit, Sestri Levante Hospital, Via A. Terzi 44, I-16039 Sestri Levante (Genoa), Italy. Email: nefrologia{at}asl4.liguria.it
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Magnasco, G. Bacchini, A. Cappello, V. La Milia, B. Brezzi, P. Messa, and F. Locatelli Clinical validation of glucose pump test (GPT) compared with ultrasound dilution technology in arteriovenous graft surveillance Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1835 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Krivitski Pitfalls of the glucose pump test for access flow measurements Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1230 - 1231. [Full Text] [PDF]
|
|
|
|
|
|
A. Magnasco and S. Alloatti Reply Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1231 - 1231. [Full Text] [PDF]
|
|